Augmented Reality for Stroke Rehabilitation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Arshad Nawaz Malik, PhD Rehab
- Phone Number: 03334503754
- Email: arshad.nawaz@riphah.edu.pk
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46060
- Railway General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Participants falling in this category would be recruited into the study.
- age between 18 to 90 years who are diagnosed with ischemic brain injury, intracerebral hemorrhage shown by magnetic resonance imaging, or computed tomography after the onset of stroke;
- with motor impairment in the upper limb, lower limb, and/or balance;
- have no or mild spasticity on the lower limb or upper limb assessed by Modified Ashworth Scale (MAS ≤ 2); and
- have sufficient cognition to follow the instructions provided by the therapists and the computer.
Exclusion Criteria:
Participants fall in this category would be excluded of the study.
- any additional medical or psychological condition that would affect their ability to comply with the study protocol, e.g., a significant orthopedic or chronic pain condition, major post-stroke depression, epilepsy, artificial cardiac pacemaker/joint;
- have severe shoulder/arm or hip/knee contracture/ pain and;
- Pregnant women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Augmented Reality Training
Augmented reality training to Experimental group
|
Each participant will receive a standard trial consisting of 20 training sessions (2-5 sessions per week, 120 min per session) in consecutive 4-10 weeks. Each session will consist of 2-10 exercises selected by the trainer from a pool of 46 exercises. The selected exercises will be tailored based on the participant's condition and progress. The exercise pool will be designed as comprehensively as possible to cover the upper limb (22 exercises and lower limb (7 exercises) motor functions, balance ability (11 exercises), or/and coordination (6 exercises). Each exercise with a duration ranging from 3 to 23 min, and will be determined by a set of parameters that can be adjusted to the individuals dynamically according to the participant's performance. |
|
Active Comparator: Traditional Treatment
Task based training to the Control Group
|
Each participant will receive a Traditional training based on Task oriented training consisting of 20 training sessions (2-5 sessions per week, 120 min per session) in consecutive 4-10 weeks.
Exercises will be tailored based on the participant's condition and progress.
The exercises will cover the upper limb, lower limb, motor functions, balance ability and coordination.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fugl-Meyer Assessment Upper Extremity and Lower Extremity (FMA-UE and FMA-LE);
Time Frame: 10 weeks
|
The cumulative test score for all components is 226 with availability of specific subtest scores (e.g., UE maximum score is 66, LE score 34; balance score 14).
This instrument has good construct validity and high reliability (r 0.99) for determining motor function.
|
10 weeks
|
|
Berg Balance Scale (BBS);
Time Frame: 10 weeks
|
The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks.
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.
|
10 weeks
|
|
Functional Ambulation Category (FAC)
Time Frame: 10 weeks
|
The Functional Ambulation Categories (FAC) is a 6-point functional walking test that evaluates ambulation ability, determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device.
The FAC is a quick visual measurement of walking, is simple to use, easy to interpret.
The test has good interrater reliability (κ=.72) and excellent test-retest reliability (k=.950).
|
10 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life (QOL): physical and mental health using the 12-Item Short Form Health Survey (SF 12v2)
Time Frame: 10 weeks
|
The 12-Item Short Form Health Survey (SF-12v2) is a validated questionnaire widely used to assess health-related quality of life (HRQOL) focusing on both physical and mental health dimensions. The SF-12v2 consists of 12 questions that cover eight domains of health, leading to two primary summary scores: Physical Component Summary (PCS) and Mental Component Summary (MCS).The SF-12v2 exhibits high internal consistency, with Cronbach's alpha coefficients typically exceeding 0.80 for both the PCS and MCS components. |
10 weeks
|
|
User experience (UX) using questionnaires (designed based on UEQ-S)
Time Frame: 10 weeks
|
User Experience (UX) encompasses all aspects of the end-user's interaction with a company, its services, and its products.
To systematically evaluate UX, particularly in digital products.
The UEQ-S consists of 8 items that are grouped into 6 key dimensions of user experience.The UEQ-S shows high internal consistency, with Cronbach's alpha values generally exceeding 0.70 for the various dimensions, ensuring that the items within each dimension measure a coherent aspect of user experience.
|
10 weeks
|
|
Activities of Daily Living (ADL) using the Barthel Index (BI)
Time Frame: 10 weeks
|
The Barthel Index (BI) is a widely recognized tool for assessing an individual's ability to perform Activities of Daily Living (ADLs).
It evaluates the extent to which individuals can maintain self-care and functional independence.
The Barthel Index consists of 10 items.Each item is scored based on the level of independence demonstrated, with total scores ranging from 0 to 100.
Higher scores indicate greater independence in performing daily activities.
The Barthel Index exhibits high internal consistency, with Cronbach's alpha values typically above 0.80.
|
10 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Mirza Obaid Baig, MS-NMPT, Riphah International University
- Principal Investigator: Arshad Nawaz Malik, PhD Rehab, Riphah International University
- Principal Investigator: Abrish Habib Abbasi, PhD* Rehab, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REC/01997 Abrish Habib
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.